ICM Online First: CandiSep study & steroids in COVID-19

ONLINE FIRST (free access)
LATEST ARTICLES
Originals
Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study
Torres A. et al.
Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia
Meduri G. U. et al.
OPEN ACCESS
(1 → 3)-β-D-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial
Bloos F. et al.
Lasting Legacy in Intensive Care Medicine
Antibiotic prophylaxis in ICU patients: should I do or not?
Leone M. et al
Helmet noninvasive support in hypoxemic respiratory failure
Grieco D.L. et al.
Editorial
Precision medicine for corticotherapy in COVID-19
Annane D. and Meduri G.U.
Imaging in Intensive Care Medicine
Severe hemophagocytic lymphohistiocytosis in kidney transplant recipient: the etiology is on the tip of the tongue!
Vasseur M. et al.
Letters
Updated competency-based training in intensive care: next step towards a healthcare union in Europe?
Póvoa P. et al.
OPEN ACCESS
Diaphragmatic ultrasound and esophageal pressure in COVID-19 pneumonia during helmet CPAP
Steinberg I. et al.
Correspondences
Early ICU mobilisation predicting functional impairment at hospital discharge. Author’s reply
Ohbe H. et al.
The challenge of pharmacological thromboprophylaxis in ICU patients: anti-FXa activity does not constitute the simple solution. Author’s reply
Hofmaenner D.A. & Singer M.
Corrections
Correction to: Management of moderate to severe traumatic brain injury: an update for the intensivist
Meyfroidt G. et al.
More papers from the ICM Journal, here.
LATEST PODCASTS
Discover all our podcasts, here.